Frequently Asked Questions about Stryker Corporation (SYK)

Name: Stryker Corporation (SYK) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Stryker Corporation (SYK) do?

Accepted Answer

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. Thi...

Question 2

Is Stryker Corporation (SYK) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of SYK reveals an Altman Z-Score of 4.02 and a Piotroski F-Score of 5/9. These metrics, combined with its 5-year revenue trend ($25.12B most recent), help investors decide if SYK fits their risk profile.

Question 3

What is the current P/E ratio for SYK?

Accepted Answer

As of the latest trading session, Stryker Corporation (SYK) has a trailing P/E ratio of 39.16.

Question 4

Who is the CEO of Stryker Corporation?

Accepted Answer

The current Chief Executive Officer of Stryker Corporation is Kevin A. Lobo.

Question 5

What was SYK's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Stryker Corporation reported annual revenues of $25.12B (2025), $22.59B (2024), $20.50B (2023), $18.45B (2022), $17.11B (2021) respectively.

Question 6

Does SYK pay a dividend?

Accepted Answer

Stryker Corporation currently pays a dividend to its shareholders, with a trailing dividend yield of 1.04%.

Question 7

How much debt and cash flow does SYK have?

Accepted Answer

In its latest reporting period, Stryker Corporation generated $4.28B in Free Cash Flow against a total debt load of $14.86B.

Question 8

What is the Price-to-Book (P/B) ratio of Stryker Corporation?

Accepted Answer

The Price-to-Book (P/B) ratio for Stryker Corporation (SYK) is currently 5.67.

Question 9

What is the Price-to-Sales (P/S) ratio of SYK?

Accepted Answer

Based on trailing twelve-month data, Stryker Corporation (SYK) trades at a Price-to-Sales (P/S) ratio of 5.06.

Question 10

What is Stryker Corporation's Return on Equity (ROE)?

Accepted Answer

Stryker Corporation (SYK) has a Return on Equity (ROE) of 15.04%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	5B	243M	-761M	4.3B	4B
2024-12	4.2B	229M	-755M	3.5B	3.3B
2023-12	3.7B	205M	-575M	3.1B	2.9B
2022-12	2.6B	168M	-588M	2B	1.9B
2021-12	3.3B	171M	-525M	2.7B	2.6B

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-12	5B	243M	-761M	4.3B	4B
2024-12	4.2B	229M	-755M	3.5B	3.3B
2023-12	3.7B	205M	-575M	3.1B	2.9B
2022-12	2.6B	168M	-588M	2B	1.9B
2021-12	3.3B	171M	-525M	2.7B	2.6B